Cargando…

Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway

The astrocytic cystine/glutamate antiporter system x(c)(–) (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, red...

Descripción completa

Detalles Bibliográficos
Autores principales: Bentea, Eduard, De Pauw, Laura, Verbruggen, Lise, Winfrey, Lila C., Deneyer, Lauren, Moore, Cynthia, Albertini, Giulia, Sato, Hideyo, Van Eeckhaut, Ann, Meshul, Charles K., Massie, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718610/
https://www.ncbi.nlm.nih.gov/pubmed/34975413
http://dx.doi.org/10.3389/fncel.2021.796635
_version_ 1784624766287609856
author Bentea, Eduard
De Pauw, Laura
Verbruggen, Lise
Winfrey, Lila C.
Deneyer, Lauren
Moore, Cynthia
Albertini, Giulia
Sato, Hideyo
Van Eeckhaut, Ann
Meshul, Charles K.
Massie, Ann
author_facet Bentea, Eduard
De Pauw, Laura
Verbruggen, Lise
Winfrey, Lila C.
Deneyer, Lauren
Moore, Cynthia
Albertini, Giulia
Sato, Hideyo
Van Eeckhaut, Ann
Meshul, Charles K.
Massie, Ann
author_sort Bentea, Eduard
collection PubMed
description The astrocytic cystine/glutamate antiporter system x(c)(–) (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, redox balance, and neuroinflammation. In the current study, we investigated the effect of genetic xCT deletion on lactacystin (LAC)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced degeneration of the nigrostriatal pathway, as models for Parkinson’s disease (PD). Dopaminergic neurons of adult xCT knock-out mice (xCT(–/–)) demonstrated an equal susceptibility to intranigral injection of the proteasome inhibitor LAC, as their wild-type (xCT(+/+)) littermates. Contrary to adult mice, aged xCT(–/–) mice showed a significant decrease in LAC-induced degeneration of nigral dopaminergic neurons, depletion of striatal dopamine (DA) and neuroinflammatory reaction, compared to age-matched xCT(+/+) littermates. Given this age-related protection, we further investigated the sensitivity of aged xCT(–/–) mice to chronic and progressive MPTP treatment. However, in accordance with our previous observations in adult mice (Bentea et al., 2015a), xCT deletion did not confer protection against MPTP-induced nigrostriatal degeneration in aged mice. We observed an increased loss of nigral dopaminergic neurons, but equal striatal DA denervation, in MPTP-treated aged xCT(–/–) mice when compared to age-matched xCT(+/+) littermates. To conclude, we reveal age-related protection against proteasome inhibition-induced nigrostriatal degeneration in xCT(–/–) mice, while xCT deletion failed to protect nigral dopaminergic neurons of aged mice against MPTP-induced toxicity. Our findings thereby provide new insights into the role of system x(c)(–) in mechanisms of dopaminergic cell loss and its interaction with aging.
format Online
Article
Text
id pubmed-8718610
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87186102022-01-01 Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway Bentea, Eduard De Pauw, Laura Verbruggen, Lise Winfrey, Lila C. Deneyer, Lauren Moore, Cynthia Albertini, Giulia Sato, Hideyo Van Eeckhaut, Ann Meshul, Charles K. Massie, Ann Front Cell Neurosci Cellular Neuroscience The astrocytic cystine/glutamate antiporter system x(c)(–) (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, redox balance, and neuroinflammation. In the current study, we investigated the effect of genetic xCT deletion on lactacystin (LAC)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced degeneration of the nigrostriatal pathway, as models for Parkinson’s disease (PD). Dopaminergic neurons of adult xCT knock-out mice (xCT(–/–)) demonstrated an equal susceptibility to intranigral injection of the proteasome inhibitor LAC, as their wild-type (xCT(+/+)) littermates. Contrary to adult mice, aged xCT(–/–) mice showed a significant decrease in LAC-induced degeneration of nigral dopaminergic neurons, depletion of striatal dopamine (DA) and neuroinflammatory reaction, compared to age-matched xCT(+/+) littermates. Given this age-related protection, we further investigated the sensitivity of aged xCT(–/–) mice to chronic and progressive MPTP treatment. However, in accordance with our previous observations in adult mice (Bentea et al., 2015a), xCT deletion did not confer protection against MPTP-induced nigrostriatal degeneration in aged mice. We observed an increased loss of nigral dopaminergic neurons, but equal striatal DA denervation, in MPTP-treated aged xCT(–/–) mice when compared to age-matched xCT(+/+) littermates. To conclude, we reveal age-related protection against proteasome inhibition-induced nigrostriatal degeneration in xCT(–/–) mice, while xCT deletion failed to protect nigral dopaminergic neurons of aged mice against MPTP-induced toxicity. Our findings thereby provide new insights into the role of system x(c)(–) in mechanisms of dopaminergic cell loss and its interaction with aging. Frontiers Media S.A. 2021-12-17 /pmc/articles/PMC8718610/ /pubmed/34975413 http://dx.doi.org/10.3389/fncel.2021.796635 Text en Copyright © 2021 Bentea, De Pauw, Verbruggen, Winfrey, Deneyer, Moore, Albertini, Sato, Van Eeckhaut, Meshul and Massie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular Neuroscience
Bentea, Eduard
De Pauw, Laura
Verbruggen, Lise
Winfrey, Lila C.
Deneyer, Lauren
Moore, Cynthia
Albertini, Giulia
Sato, Hideyo
Van Eeckhaut, Ann
Meshul, Charles K.
Massie, Ann
Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
title Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
title_full Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
title_fullStr Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
title_full_unstemmed Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
title_short Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
title_sort aged xct-deficient mice are less susceptible for lactacystin-, but not 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-, induced degeneration of the nigrostriatal pathway
topic Cellular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718610/
https://www.ncbi.nlm.nih.gov/pubmed/34975413
http://dx.doi.org/10.3389/fncel.2021.796635
work_keys_str_mv AT benteaeduard agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT depauwlaura agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT verbruggenlise agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT winfreylilac agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT deneyerlauren agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT moorecynthia agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT albertinigiulia agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT satohideyo agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT vaneeckhautann agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT meshulcharlesk agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway
AT massieann agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway